000			01600cam a2200253 4500500
005			20250123100211.0
041			_afre
042			_adc
100	1	0	_aWolf, Federica I. _eauthor
700	1	0	_a Trapani, Valentina _eauthor
245	0	0	_aMagnesium and vitamin D in long COVID syndrome; do they help?
260			_c2023.
500			_a34
520			_aSince the start of the COVID-19 pandemic, it has become increasingly clear that the disease can have relevant multisystemic and long-term effects, and several studies have attempted to identify key determinants of the disease course. Here we discuss recent evidence suggesting that, in long COVID patients, combined magnesium and vitamin D deficiencies associate with a higher number of clinical manifestations, as compared to patients with normal levels of both nutrients. We highlight the potential synergistic effects of these deficiencies and propose that future studies should explore a causal link with the risk of developing long COVID. Most importantly, randomized clinical trials are needed to determine if magnesium and vitamin D supplementation can improve long COVID symptoms, providing a safe and affordable support therapy to the benefit of patients and society.
690			_aCOVID-19
690			_ainfection
690			_aSARS-CoV-2
690			_amicronutrients
690			_aPACS
690			_ahypomagnesemia
690			_aLCD
786	0		_nMagnesium Research | 36 | 4 | 2023-10-09 | p. 49-53 | 0953-1424
856	4	1	_uhttps://shs.cairn.info/revue-magnesium-research-2023-4-page-49?lang=en&redirect-ssocas=7080
999			_c755781 _d755781